MDA-MB-415 Cells
| Unit |
3 x 10^6 cells/ml |
|---|---|
| Cell Type |
Tumor Cells |
| Tissue Type |
Breast cancer cell lines |
| Organism |
Human |
| Donor History |
Adenocarcinoma |
| Growth Properties |
Adherent |
| Growth Conditions |
Culture medium: DMEM:Ham's F12 (1:1) ,w: 3.1 g/L Glucose ,w: 2.5 mM L-Glutamine ,w: 15 mM HEPES ,w: 0.5 mM Sodium pyruvate ,w: 1.2 g/L NaHCO3 (Cytion article number 820400a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium ,we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability ,or CM-1 (Cytion catalog number 800100) ,which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C ,5% CO2 ,humidified atmosphere. |
| Immortalization Method | |
| Full Information |
The MDA-MB-415 cell line is derived from a metastatic site of an adult female patient with breast adenocarcinoma. These cells are epithelial in nature and exhibit characteristics typical of mammary gland epithelial cells. They are known for their utility in studying the molecular and cellular mechanisms underlying breast cancer, including hormone receptor activity and gene expression profiles. The MDA-MB-415 cell line is estrogen receptor-positive (ER+) and HER2 negative, making it particularly valuable for research focused on hormone-responsive breast cancers. Researchers utilize these cells to investigate the role of estrogen signaling in breast cancer progression and to evaluate the efficacy of anti-estrogen therapies.
In terms of growth characteristics, MDA-MB-415 cells grow as adherent monolayers and require a nutrient-rich culture medium to maintain optimal growth and viability. These cells exhibit a moderate doubling time, which makes them suitable for various in vitro assays, including proliferation, apoptosis, and drug sensitivity studies. The genetic profile of MDA-MB-415 cells has been extensively characterized, revealing key mutations and gene expression patterns that are relevant to breast cancer biology. This cell line serves as a critical model for understanding the complex interactions between cancer cells and their microenvironment, aiding in the development of novel therapeutic strategies.
Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.
Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Třepačky
Suché lázně
Fluorometry
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Čtečky identifikačních čipů
Termočipy
Biochemie
Imunoanalýza

